Researchers have confirmed for the first time that two of the top genomic databases, which are in wide use today by clinical geneticists, reflect a measurable bias toward genetic data based on European ancestry over that of African ancestry. The results of their study were published in the latest issue of Nature Communications.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. To reduce this risk, doctors have prescribed low molecular weight heparin. But some researchers argue that aspirin may be just as effective. A comprehensive new study will try to resolve this question.
An international group of researchers has for the first time identified a set of 30 inherited recessive genes that play a role in intellectual disability, a neurodevelopmental disorder that affects as many as 213 million people around the world.
Using a new, lightning-fast camera paired with an electron microscope, University of Maryland School of Medicine scientists have captured images of one of the smallest human proteins to be “seen” with a microscope.
The Center for Vaccine Development at the University of Maryland School of Medicine’s Institute for Global Health has been chosen as one of three study sites in a human safety trial of a new Zika vaccine. The early-stage study will evaluate the experimental vaccine’s safety and ability to generate an immune system response in participants.
For more than a century, neuroscientists have known that nerve cells talk to one another across the small gaps between them, a process known as synaptic transmission. But the details of how this crucial aspect of brain function occurs have remained elusive. Now, new research has for the first time elucidated details about the architecture that Allows Brain Cells to Communicate. The paper was published today in the journal Nature.
Most people don’t think of fungal infections as deadly – they are generally viewed as annoyances – athlete’s foot, for instance. But for many weakened patients in the hospital, fungal infections can be life threatening. Now, a new study has provided insights into one of these microbes, the Mucorales fungi, which can cause fatal infections.
Charles B. Simone, II has been named the new Medical Director of the Maryland Proton Treatment Center. Dr. Simone will continue to define and implement processes ensuring that MPTC is integrated into the radiation oncology program and the University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center/System, and the University of Maryland School of Medicine.
The Center for Vaccine Development (CVD) has been awarded a large grant for research that will help determine why so many children under five are dying in the world’s poorest countries. The grant will fund use of an innovative alternative to traditional autopsy known as minimally invasive tissue sampling.
In a milestone years in the making, a vaccine to prevent cholera was approved today by the U.S. Food and Drug Administration (FDA). The vaccine, Vaxchora, is the only approved vaccine in the U.S. for protection against cholera. Its licensure allows for use in people traveling to regions in which cholera is common, including travelers, humanitarian aid workers, and the military.
Each year, influenza causes between 250,000 and half a million deaths around the world. Now a new study has shown that immunizing mothers against flu can decrease by 70 percent the risk of their infants getting flu during the first four months after birth. This is the largest study so far to show that maternal vaccination against flu is feasible and effective in resource-poor environments.
It is one of the most famous paintings in American history: Christina’s World, by Andrew Wyeth. The subject in the painting suffered from a mysterious disorder that took away her ability to walk. Her disease has never been diagnosed. Now, a leading neurologist has pinpointed a diagnosis.
Zeljko Vujaskovic, MD, PhD, an internationally recognized physician scientist and Professor of Radiation Oncology at the University of Maryland School of Medicine (UM SOM), will receive the 2016 J. Eugene Robinson Award at the annual Society for Thermal Medicine Meeting in New Orleans, held April 11 to 15. Dr. Vujaskovic, who is also Director of the Division of Translational Radiation Sciences in the UM SOM Department of Radiation Oncology, and Director of the Maryland Proton Alliance at UM SOM, will receive the award in recognition of his contributions to hyperthermic oncology, the use of heat to treat cancer. At the event, Dr. Vujaskovic will also present a lecture on the reemerging role of thermal therapy in cancer treatment.
The the University of Maryland School of Medicine Program in Health Disparities and Population Health now has a new home in the Department of Epidemiology and Public Health.
The University of Maryland School of Medicine has appointed Peter B. Crino as Chairman of the department of neurology. Dr. Crino has spent his career studying and developing new models for treating some of the most difficult and complex disorders of the brain. He is an expert in defining developmental disorders associated with intractable epilepsy.
New research has provided more evidence that an innovative treatment strategy may help prevent brain swelling and death in stroke patients. J. Marc Simard, professor of neurosurgery at the University of Maryland School of Medicine, along with colleagues at Yale University and Massachusetts General Hospital, found that Cirara, an investigational drug, powerfully reduced brain swelling and death in patients who had suffered a type of large stroke called malignant infarction, which normally carries a high mortality rate.
The University of Maryland School of Medicine announced today that the Maryland Proton Treatment Center has treated its first cancer patients with proton therapy at a new $200 million facility in the University of Maryland BioPark in West Baltimore.
The Maryland House of Delegates and House Speaker Michael E. Busch, has announced that University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA and University of Maryland Medical System President and CEO Robert Chrencik, MBA, are recipients of the “Speaker’s Medallion,” the highest honor given to the public by the leader of the Maryland House of Delegates.
William F. Regine, Chairman of the Department of Radiation Oncology at the University of Maryland School of Medicine, along with Dean E. Albert Reece, today announced the establishment of the Maryland Proton Alliance, a new organizational framework for proton therapy at the school that may serve as a national model for patient-centered cancer care. The Alliance will be led by Zeljko Vujaskovic, Professor in the Department of Radiation Oncology and head of the department’s Division of Translational Radiation Sciences.
As it spreads throughout South and Central America and beyond, Zika presents a unique challenge to health officials and to the public. University of Maryland School of Medicine infectious disease specialists can offer insight into the virus, its potential hazards, and the possibility that it may spread to the U.S.
The White House has awarded Robert E. Fischell, ScD, a member of the University of Maryland School of Medicine Board of Visitors, the National Medal of Technology and Innovation, the highest honor for technological achievement bestowed by the president of the United States.
Research performed by scientists at the University of Maryland School of Medicine has led to FDA approval for the use of a drug to treat the deleterious effects of radiation exposure following a nuclear incident. The drug, Neulasta, is one of a few that have been approved for the treatment of acute radiation injury.
The University of Maryland School of Medicine has been selected as a key contractor by the Biomedical Advanced Research and Development Authority for its Radiation Nuclear Animal Model Development program.
The Center for Vaccine Development at the University of Maryland School of Medicine will participate in a partnership with industry to develop a vaccine to prevent a group of deadly bacterial infections that occur commonly among hospital patients.
In an event that showed the growing breadth and depth of research at the University of Maryland School of Medicine, more than 500 attendees participated in the Third Annual Festival of Science on December 11.
The Association of American Medical Colleges announced that University of Maryland School of Medicine Dean E. Albert Reece will receive the 2015 David E. Rogers Award, which honors a medical school faculty member who has made major contributions to improving the health and health care of the American people.
After eight years of analysis, scientists from around the world have completed an unprecedented project to delineate a wide spectrum of human genetic variation. This enormous catalog of data, known as the 1000 Genomes Project, will yield insights for decades. Scientists from the University of Maryland School of Medicine played a key role in the consortium, and co-authored two papers published this week about the effort in the current issue of the journal Nature.
New research from scientists at the University of Maryland School of Medicine (UM SOM) has found that tiny lumps of calcium phosphate may be an important triggering factor for age-related macular degeneration (AMD), a degenerative eye disease that can cause severe vision loss and blindness. This is the first time these mineral deposits have been implicated in the disease, which affects more than 10 million Americans. The article appeared in the latest issue of the Proceedings of the National Academy of Sciences.
The Baltimore study is the second Ebola vaccine trial being led by the University of Maryland School of Medicine CVD, the first currently taking place in Mali, West Africa. The Mali trial is being performed by CVD-Mali in partnership with the Ministry of Health of Mali.
To address the growing mental health needs of today's youth, the University of Maryland School of Medicine's Center for School Mental Health Analysis and Action will bring together mental health experts, educators and policy makers at a two-day conference to discuss ways to bring mental health services to youth in the school setting.
Experts from the professional schools at the University of Maryland, Baltimore and the University of Maryland Medical Center can discuss many different aspects of Hurricane Katrina and its aftermath.
Scientists have identified a way to prevent Type I diabetes in rats that are genetically prone to develop the disease. The discovery could one day lead to the prevention, and possibly to the treatment, of autoimmune diseases such as Type 1 diabetes.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right